IEIvan Ergelasev

Ivan Ergelasev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ivan Ergelasev has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Ivan Kuhajda

    University of Novi Sad, Faculty of Medicine Novi Sad, Novi Sad, Serbia + Institute for Pulmonary Diseases of Vojvodina, Thoracic Surgery Clinic, Novi Sad - Sremska Kamenica, Serbia

    2 shared publications
  • Marko Bojovic

    University of Novi Sad, Faculty of Medicine in Novi Sad, Novi Sad, Serbia; Clinic for Radiation Oncology, Oncology Institute of Vojvodina, Novi Sad, Serbia

    2 shared publications
  • Nensi Lalic

    Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia

    2 shared publications
  • Aleksandra Vulin

    University of Novi Sad, Faculty of Medicine Novi Sad, Novi Sad, Serbia + Institute for Cardiovascular Diseases of Vojvodina, Clinic for cardiology, Novi Sad - Sremska Kamenica, Serbia

    1 shared publication
  • Marko Galić

    Institute for Balkan Studies of the Serbian Academy of Sciences and Arts

    1 shared publication
  • Sanja Ergelasev

    Institute for Cardiovascular Diseases of Vojvodina, Clinic for cardiology, Novi Sad - Sremska Kamenica, Serbia

    1 shared publication

Latest Publications

  • Open Access

    Can heart rate variability be utilised to predict compensatory sweating after endoscopic thoracic sympathicotomy in patients with primary focal hyperhidrosis?

    by Ivan Ergelasev, Ivan Kuhajda, Stefan Andric, Sanja Ergelasev, Aleksandra Vulin, Sinisa Maksimovic, Srdjan Gavrilovic, Uros Batranovic, Marko Bojovic, Nensi Lalic

    Introduction/Objective. Hyperhidrosis is a condition of pathological excessive sweating that exceeds the body’s physiological requirements for thermoregulation. Endoscopic thoracic sympathicotomy (ETS) is a commonly used treatment for primary focal hyperhidrosis (PFH); however, it may result in compensatory sweating (CS), which represents its most frequent postoperative complication. This study aimed to investigate whether heart rate variability (HRV) parameters could predict CS. Methods. A prospective single-center study was conducted in 100 patients with primary focal hyperhidrosis (PFH) who underwent ETS. Preoperatively, all patients underwent 24-hour Holter ECG monitoring to assess standard HRV parameters. ETS was performed by transection of the sympathetic chain at the level of the third (R3) and fourth rib (R4), including the accessory Kuntz fibers. One month after surgery, the presence and severity of CS were assessed. Results. CS was absent in 61% of patients (p=0.028). Mild CS was the most common form (p < 0.01). No statistically significant differences were observed in the analyzed preoperative HRV parameters between patients with and without CS (p > 0.05), including the low-frequency (LF)/high-frequency (HF) ratios, which represent balanced autonomic activity (LF/HF < 2) and sympathetic predominance (LF/HF ≥ 2). ROC curve analysis showed that age had significant predictive accuracy for CS (AUC 0.7333; 95% CI 0.634-0.833; p < 0.01), with an optimal cutoff of 23.5 years (sensitivity 0.82, specificity 0.47). Conclusion. HRV parameters cannot reliably predict CS following bilateral ETC in patients with PFH. The study confirmed that the optimal age for surgery is below 23.5 years.

  • Open Access

    Evaluation of the quality of life 10 years after bilateral thoracoscopic sympathicotomy in subjects with primary focal hyperhidrosis

    by Ivan Ergelasev, Ivan Kuhajda, Marko Galic, Nensi Lalic, Marko Bojovic

    Introduction/Objective. Primary focal hyperhidrosis (PFH) is an idiopathic condition where excessive sweating affects one or more body regions, including axillae, palms, soles, and/or face. Most studies on quality-of-life (QoL) focus on the period up to one year after bilateral thoracoscopic sympathectomy (BTS). This study aims to determine the 10-year trend in QoL among patients from the Republic of Serbia with palmar-plantar-axillary PFH, treated with BTS at the R3?R4 level. A secondary goal is to ascertain the existence of compensatory sweating. Methods. All patients underwent a standardized BTS in a single act, through the cutting of ganglia with ultrasonic scissors at the R3?R4 level. For data collection, patients completed the ?Hyperhidrosis Quality of Life Questionnaire,? and the Hyperhidrosis Disease Severity Scale, preoperatively, postoperatively within 30 days, and 10 years after BTS. Results. The total sample consisted of 103 subjects who completed all three questionnaires. Considering the improvement in QoL from the group excellent, good, and average, the postoperative improvement was immediately postoperative in 88.4% of patients, while in the ten-year period, it was 87.4%. No statistically significant differences were found between the assessment of life satisfaction after 30 days and 10 years after BTS. Out of the total number of operated patients, two patients (1.94%) characterized their compensatory sweating as very pronounced. Conclusion. After 10 years from BTS, the QoL remains at an exceptionally high level, with an annual trend of decline of about 0.1%.